|
(V1766) |
Matrix metalloproteinase 13 (MMP13) knock-out is beneficial for the outcome after myocardial infarction |
| |
|
D. Lindner, S. Krüger, V. Lang, L. Bacmeister, S. Voß, P. M. Becher, M. Schwarzl, A. El-Armouche, S. Blankenberg, D. Westermann (Hamburg, Dresden) |
|
|
Diskussion |
|
(V1767) |
Aldosterone blockade by spironolacton in combination with high physical activity in essential hypertension: do they interact? |
| |
|
R. Schreckenberg, S. Simsekyilmaz, C. Troidl, F. Atmanspacher, B. Niemann, H. Kutsche, K.-D. Schlüter (Gießen, Düsseldorf) |
|
|
Diskussion |
|
(V1768) |
Comparative analyses of left and right ventricular adaptations to pressure overload in rats |
| |
|
F. Knapp, B. Niemann, L. Li, S. Rohrbach (Gießen) |
|
|
Diskussion |
|
(V1769) |
The non-steroidal mineralocorticoid receptor antagonist finerenone prevents structural cardiac remodeling |
| |
|
D. Lavall, P. Kolkhof, M. Böhm, U. Laufs (Leipzig, Wuppertal, Homburg/Saar) |
|
|
Diskussion |
|
(V1770) |
Does modification of activity regimes optimize the effect of high physical activity on hypertensive heart disease? |
| |
|
R. Schreckenberg, C. Troidl, B. Niemann, K.-D. Schlüter (Gießen) |
|
|
Diskussion |
|
(V1771) |
Differential Junctophilin-2 expression, loss-of-function and therapeutic expression in atrial hypertrophy |
| |
|
J. Pawlowitz, S. Brandenburg, T. Kohl, B. Eikenbusch, X. Wehrens, S. Lehnart (Göttingen; Houston, US) |
|
|
Diskussion |